Comparative costs of gemcitabine/cisplatin, paclitaxel/carboplatin and vinorelbine/cisplatin in the treatment of non-small cell lung cancer in Germany

被引：0
|
作者：
Bischoff, H
Hamann, M
Stynes, G
Bhalla, S
Tilden, D
Kielhorn, A
机构：
[1] Stabsstelle Med Management, Heidelberg, Germany
[2] Eli Lilly Germany, Bad Homburg, Germany
[3] M TAG Ltd, Hammersmith, England
[4] Eli Lilly, Windlesham, Surrey, England
来源：
VALUE IN HEALTH | 2004年 / 7卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)65750-6
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：674 / 674
页数：1
相关论文
共 50 条
  • [31] Gemcitabine, vinorelbine and cisplatin combination chemotherapy in advanced non-small cell lung cancer:: a phase II trial
    Laack, E
    Mende, T
    Dürk, H
    Kneba, M
    Dickgreber, N
    Welte, T
    Müller, T
    Scholtze, J
    Graeven, U
    Jasiewicz, Y
    Edler, L
    Hossfeld, DK
    EUROPEAN JOURNAL OF CANCER, 2002, 38 (05) : 654 - 660
  • [32] Randomized phase II trial of sequential chemotherapy in advanced non-small cell lung cancer (SWOG 9806): Carboplatin/gemcitabine followed by paclitaxel or cisplatin/vinorelbine followed by docetaxel
    Edelman, MJ
    Clark, JI
    Chansky, K
    Albain, K
    Bhoopalam, N
    Weiss, GR
    Giguere, JK
    Kelly, K
    Crowley, J
    Gandara, DR
    CLINICAL CANCER RESEARCH, 2004, 10 (15) : 5022 - 5026
  • [33] A retrospective comparison of adjuvant chemotherapeutic regimens for non-small cell lung cancer (NSCLC): Paclitaxel plus carboplatin versus vinorelbine plus cisplatin
    Chang, Won Jin
    Sun, Jong-Mu
    Lee, Ji Yean
    Ahn, Jin Seok
    Ahn, Myung-Ju
    Park, Keunchil
    LUNG CANCER, 2014, 84 (01) : 51 - 55
  • [34] Cisplatin plus vinorelbine as induction treatment in stage IIIA non-small cell lung cancer
    Palka, Magda
    Sanchez, Antonio
    Cordoba, Mar
    Diaz Nuevo, Gema
    Varela De Ugarte, Andres
    Cantos, Blanca
    Mendez, Miriam
    Calvo, Virginia
    Maximiano, Constanza
    Provencio, Mariano
    ONCOLOGY LETTERS, 2017, 13 (03) : 1647 - 1654
  • [35] Triplet chemotherapy with vinorelbine, gemcitabine, and cisplatin for advanced non-small cell lung cancer: a phase II study
    Niho, S
    Kubota, K
    Goto, K
    Ohmatsu, H
    Matsumoto, T
    Kakinuma, R
    Nishiwaki, Y
    BRITISH JOURNAL OF CANCER, 2002, 87 (12) : 1360 - 1364
  • [36] Paclitaxel and carboplatin followed by concomitant paclitaxel, cisplatin, and radiotherapy for inoperable stage III non-small cell lung cancer
    Mattson, K
    Isokangas, OP
    Halme, M
    Joensuu, H
    SEMINARS IN ONCOLOGY, 1999, 26 (01) : 72 - 72
  • [37] Biweekly triplet chemotherapy with gemcitabine, cisplatin and vinorelbine for advanced chemotherapy naive non-small cell lung cancer
    Keskin, Serkan
    Tas, Faruk
    Ekenel, Meltem
    Kilic, Leyla
    Sen, Fatma
    Yildiz, Ibrahim
    Karabulut, Senem
    Ciftci, Rumeysa
    Vatansever, Sezai
    TUMORI, 2013, 99 (04) : 463 - 468
  • [38] Cisplatin, ifosfamide and vinorelbine combination in advanced non-small cell lung cancer
    Baron, FJ
    Cueva, JF
    Vazquez, F
    Candamio, S
    Calvo, M
    Sanz, A
    Irigoyen, A
    Menendez, MD
    Huidobro, C
    Lopez, R
    ANNALS OF ONCOLOGY, 1998, 9 : 99 - 99
  • [39] Gemcitabine, Vinorelbine, and Cisplatin in the Treatment of Advanced Nonsmall Cell Lung Cancer
    Hasturk, Serap
    Hatabay, Nilgun
    Ece, Ferah
    Karatasli, Meltem
    Hanta, Ismail
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2009, 32 (03): : 280 - 285
  • [40] Gemcitabine and vinorelbine combinations in the treatment of non-small cell lung cancer
    Herbst, RS
    Lilenbaum, R
    SEMINARS IN ONCOLOGY, 1999, 26 (05) : 67 - 70
12345